HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Pulmonary valve disorder — Clinical Guidelines

Overview

Pulmonary valve disorders, including pulmonary regurgitation (PR) and pulmonary stenosis (PS), significantly impact cardiac function by disrupting normal blood flow from the right ventricle to the pulmonary artery. These conditions often arise secondary to congenital heart defects such as tetralogy of Fallot, truncus arteriosus, or following surgical interventions like right ventricular outflow tract (RVOT) reconstructions. Patients with these disorders frequently experience symptoms like dyspnea, fatigue, and exercise intolerance, which can progress to right ventricular dysfunction, arrhythmias, and heart failure if left untreated. Early recognition and intervention are crucial in day-to-day practice to prevent long-term complications and improve quality of life 1 2 8.

Pathophysiology

Pulmonary valve disorders stem from structural abnormalities or functional impairments that disrupt the unidirectional flow of blood through the right ventricular outflow tract. In pulmonary regurgitation, the valve fails to close properly, leading to backflow of blood into the right ventricle, causing chronic volume overload and subsequent right ventricular dilation and dysfunction. This volume overload can trigger maladaptive remodeling of the right ventricle, including hypertrophy and eventual dysfunction, potentially leading to arrhythmias and heart failure 2 7. Pulmonary stenosis, on the other hand, results from narrowing or obstruction at the valve level, impeding blood flow and increasing right ventricular pressures, which can also lead to right ventricular hypertrophy and failure if untreated 1 17.

Epidemiology

The incidence of pulmonary valve disorders is closely tied to the prevalence of congenital heart disease (CHD), affecting approximately 5 to 8 per 1,000 live births globally 3 4. These conditions disproportionately impact pediatric and young adult populations, with idiopathic pulmonary regurgitation being rare in adults without underlying CHD. Specific risk factors include prior surgical interventions, congenital anomalies like tetralogy of Fallot, and acquired conditions such as rheumatic heart disease or carcinoid syndrome 2 18. Trends over time show a decrease in mortality rates due to advancements in surgical and interventional cardiology, but pulmonary valve disorders remain significant contributors to morbidity in CHD patients 5 9.

Clinical Presentation

Patients with pulmonary valve disorders typically present with symptoms reflecting right ventricular dysfunction, including dyspnea on exertion, fatigue, and peripheral edema. Acute exacerbations may manifest as syncope or angina-like chest pain due to increased right ventricular pressures. Red-flag features include signs of right heart failure (e.g., jugular venous distension, ascites), arrhythmias, and unexplained weight loss. Physical examination often reveals a systolic murmur indicative of regurgitation or a harsh systolic ejection murmur for stenosis. These presentations necessitate prompt diagnostic evaluation to confirm the underlying pathology 1 2 15.

Diagnosis

The diagnostic approach for pulmonary valve disorders involves a combination of clinical assessment, imaging modalities, and hemodynamic evaluation. Specific Criteria and Tests:

Echocardiography: Essential for initial assessment; Doppler echocardiography quantifies PR severity (e.g., regurgitant jet area, vena contracta width) 5 13.

Cardiac MRI/CT: Provides detailed anatomical and functional assessment, particularly useful for complex cases or when echocardiography is limited 9.

Catheterization: Gold standard for definitive hemodynamic assessment; measures right ventricular pressures, oxygen saturation gradients, and quantifies PR severity (e.g., regurgitant fraction > 5% indicates significant PR) 1 17.

Differential Diagnosis:

- Pulmonary Hypertension: Elevated pulmonary artery pressures without significant valve dysfunction. - Cor Triatriatum: Obstructive anomaly of the right ventricular outflow tract. - Right Ventricular Myocardial Infarction: Can mimic PR due to regional wall motion abnormalities 2 15.

Management

Surgical Pulmonary Valve Replacement (SPVR)

Indications: Severe PR or PS unresponsive to medical therapy, significant right ventricular dysfunction.

Procedure: Use of bioprosthetic valves (e.g., Resilia, Perimount) or mechanical valves in select cases.

Considerations: Risk of re-operation due to valve degeneration and need for anticoagulation with mechanical valves 3 19.

Transcatheter Pulmonary Valve Replacement (TPVR)

Indications: Patients with RVOT anatomy amenable to transcatheter approaches, recurrent surgical failures, or preference for minimally invasive options.

Devices: Harmony TPV, Melody valve, Sapien valve, Salus valve.

Procedure Details:

- Harmony TPV: Suitable for native or repaired RVOT; sizes 22mm and 25mm available. - Catheter-based deployment: Ensuring proper sizing and positioning to avoid complications like stent malposition or obstruction. - Post-procedure Monitoring: Echocardiography at discharge, follow-up at 1-3 months, then annually to assess valve function and cardiac remodeling 1 4 8.

Medical Management

Initial Approach: Diuretics (e.g., furosemide) for volume overload, ACE inhibitors/ARBs for right ventricular afterload reduction.

Symptom Control: Beta-blockers for rate control in arrhythmias, anticoagulation as needed.

Monitoring: Regular echocardiograms, clinical assessments, and hemodynamic evaluations to guide therapy adjustments 2 15.

Complications

Acute Complications: Arrhythmias (e.g., ventricular tachycardia), acute right heart failure, device embolization.

Long-term Complications: Valve dysfunction (regurgitation, stenosis), right ventricular remodeling, endocarditis, need for re-intervention.

Management Triggers: Persistent symptoms, hemodynamic instability, imaging evidence of valve dysfunction or structural changes; referral to a specialist for further evaluation and intervention is warranted 1 7 17.

Prognosis & Follow-up

The prognosis for patients with pulmonary valve disorders varies based on the severity of the condition and the effectiveness of intervention. Favorable outcomes are observed with timely and appropriate treatment, particularly with transcatheter approaches showing sustained valve competence and improved quality of life over midterm follow-up (3-5 years). Key prognostic indicators include initial hemodynamic severity, right ventricular function, and adherence to follow-up protocols. Recommended follow-up intervals include:

Initial Follow-up: Within 1-3 months post-procedure.

Subsequent Monitoring: Annually with echocardiography and clinical assessment to evaluate valve function, right ventricular remodeling, and overall cardiac status 1 8 10.

Special Populations

Pediatrics

Considerations: Growth and development impact valve sizing and long-term durability; frequent follow-up to monitor valve function and RVOT adaptation.

Management: Early intervention with transcatheter options when feasible to minimize surgical trauma 1 14.

Adults with Congenital Heart Disease

Challenges: Higher risk of valve degeneration and need for re-intervention; careful selection of valve type (bioprosthetic vs. mechanical) based on life expectancy and anticoagulation risk.

Monitoring: More frequent surveillance due to accelerated wear and tear compared to the general population 2 15.

Elderly Patients

Considerations: Comorbidities and frailty influence surgical versus transcatheter options; emphasis on minimally invasive techniques to reduce perioperative risks.

Management: Tailored to individual health status, prioritizing quality of life and symptom relief 1 15.

Key Recommendations

Use Transcatheter Pulmonary Valve Replacement (TPVR) for Patients with Suitable Anatomy: TPVR is effective for managing severe PR and PS in patients with anatomically appropriate RVOT, offering sustained valve competence and improved cardiac remodeling (Evidence: Strong) 1 4.

Echocardiography as Primary Diagnostic Tool: Utilize echocardiography for initial assessment and serial monitoring to quantify PR severity and evaluate valve function (Evidence: Strong) 5 13.

Incorporate Cardiac MRI/CT for Complex Cases: Employ advanced imaging modalities for detailed anatomical and functional evaluation, especially in complex congenital heart disease scenarios (Evidence: Moderate) 9.

Regular Follow-up Monitoring: Schedule annual echocardiograms and clinical assessments post-intervention to monitor valve function and right ventricular remodeling (Evidence: Moderate) 8 10.

Consider Bioprosthetic Valves in Adults: Opt for bioprosthetic valves in adults due to lower long-term anticoagulation requirements, balancing durability with patient-specific factors (Evidence: Moderate) 3 19.

Manage Right Ventricular Volume Overload Aggressively: Initiate diuretics and ACE inhibitors early to mitigate right ventricular dilation and dysfunction (Evidence: Moderate) 2 15.

Monitor for Arrhythmias and Device-Related Complications: Regularly screen for arrhythmias and complications such as valve dysfunction or embolization, especially in the acute and subacute post-procedure period (Evidence: Moderate) 1 7.

Tailor Management to Special Populations: Adapt treatment strategies for pediatric, adult CHD, and elderly patients considering growth, comorbidities, and life expectancy (Evidence: Expert opinion) 1 14 15.

Evaluate for Hybrid Approaches in Complex Cases: Consider hybrid procedures involving surgical and transcatheter techniques for patients with challenging anatomies (Evidence: Expert opinion) 16.

Promote Patient Education and Lifestyle Modifications: Educate patients on symptom recognition and lifestyle adjustments to optimize outcomes and quality of life (Evidence: Expert opinion) 15.

References

1 Morray BH, Gillespie MJ, Cheatham JP, Salavitabar A, Peng L, Jones TK et al.. Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients. Circulation. Cardiovascular interventions 2025. link 2 Chongmelaxme B, Kua KP, Amornvetchayakul C, Chawviriyathep N, Kerdklinhom T. Comparative effects of transcatheter versus surgical pulmonary valve replacement: A systematic review and meta-analysis. PloS one 2025. link 3 Seadler BD, Holland HK, Novalija J, Schena S, Almassi GH. Early inspiris resilia valve failure in a patient with idiopathic pulmonary valve regurgitation. Journal of cardiothoracic surgery 2025. link 4 Zhou Z, Tian M, Tu J, Zhang Y, Zhuang J, Wen S et al.. Novel Transthoracic Pulmonary Valve Implantation Using Self-Expanding Salus Valve: A Prospective Study of Safety and Mid-Term Outcomes. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2025. link 5 Kemaloglu Oz T, Kavalerchyk V, Hristova K, Felix ADS, Sivashanmugarajah AS, Baumann AA et al.. From Traditional to Cutting-Edge: Transforming Pulmonary Valve Assessment With Advanced Echocardiography Techniques. Echocardiography (Mount Kisco, N.Y.) 2025. link 6 Gillespie MJ, Maschietto N, Aboulhosn JA, Balzer DT, Qureshi AM, McElhinney DB. Extravascular protrusion of the Alterra adaptive prestent identified on surveillance computed tomography imaging. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2024. link 7 Steinberg ZL, Cabalka AK, Balzer DT, Asnes JD, Morray BH, Gillespie MJ et al.. Right ventricular outflow tract obstruction associated with neointimal tissue accumulation and distortion of the Harmony TPV25 stent frame: Potential mechanisms and treatment. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2023. link 8 Gillespie MJ, McElhinney DB, Jones TK, Levi DS, Asnes J, Gray RG et al.. 1-Year Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Clinical Trial Participants. JACC. Cardiovascular interventions 2023. link 9 Karsenty C, Alattar Y, Mousseaux E, Marcilhacy G, Gencer U, Craiem D et al.. 4D flow magnetic resonance imaging to assess right ventricular outflow tract in patients undergoing transcatheter pulmonary valve replacement. Revista espanola de cardiologia (English ed.) 2023. link 10 Huang KA, Dai X, Liao D, Li Q. Balloon Valvuloplasty via the Pulmonary Artery Trunk for Treating Neonates With Severe Pulmonary Valve Disease. The heart surgery forum 2021. link 11 Borenstein N, Chetboul V, Passavin P, Morlet A, Fernandez-Parra R, Carazo Arias LE et al.. Successful transcatheter pulmonary valve implantation in a dog: first clinical report. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology 2019. link 12 Kan CD, Wang JN, Lin CH, Chen WL, Lu PJ, Chan MY et al.. Handmade trileaflet valve design and validation for patch-valved conduit reconstruction using generalized regression machine learning model. Technology and health care : official journal of the European Society for Engineering and Medicine 2018. link 13 Elsayed M, Hsiung MC, Nanda NC, Alratroot A, Turaga NSS. Three-dimensional transthoracic echocardiographic identification of individual cusps of the pulmonary valve: Potential misidentification by the two-dimensional technique. Echocardiography (Mount Kisco, N.Y.) 2018. link 14 Gillespie MJ, Benson LN, Bergersen L, Bacha EA, Cheatham SL, Crean AM et al.. Patient Selection Process for the Harmony Transcatheter Pulmonary Valve Early Feasibility Study. The American journal of cardiology 2017. link 15 Pignatelli RH, Noel C, Reddy SCB. Imaging of the pulmonary valve in the adults. Current opinion in cardiology 2017. link 16 Abu Saleh WK, Lin CH, Breinholt JP, Ramlawi B. Hybrid Approach to Pulmonary Valve Replacement with Melody Prosthesis Following Pulmonary Banding. Journal of cardiac surgery 2016. link 17 Jonas SN, Kligerman SJ, Burke AP, Frazier AA, White CS. Pulmonary Valve Anatomy and Abnormalities: A Pictorial Essay of Radiography, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI). Journal of thoracic imaging 2016. link 18 Fuglsang S, Heiberg J, Hjortdal VE. Severe Pulmonary Valve Regurgitation 40 Years After Blunt Chest Trauma. The Annals of thoracic surgery 2015. link 19 Grohmann J, Höhn R, Fleck T, Stiller B, Neumann E, Sigler M et al.. No-React® Injectable BioPulmonic™ valves re-evaluated: discouraging follow-up results. Interactive cardiovascular and thoracic surgery 2015. link 20 Rajiah P, Nazarian J, Vogelius E, Gilkeson RC. CT and MRI of pulmonary valvular abnormalities. Clinical radiology 2014. link 21 Saremi F, Gera A, Ho SY, Hijazi ZM, Sánchez-Quintana D. CT and MR imaging of the pulmonary valve. Radiographics : a review publication of the Radiological Society of North America, Inc 2014. link 22 Voges I, Bräsen JH, Entenmann A, Scheid M, Scheewe J, Fischer G et al.. Adverse results of a decellularized tissue-engineered pulmonary valve in humans assessed with magnetic resonance imaging. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2013. link 23 Faza N, Kenny D, Kavinsky C, Amin Z, Heitschmidt M, Hijazi ZM. Single-center comparative outcomes of the Edwards SAPIEN and Medtronic Melody transcatheter heart valves in the pulmonary position. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2013. link 24 Iosifescu AG, Dorobantu LF, Anca TM, Iliescu VA. Surgical treatment of a pulmonary artery aneurysm due to a regurgitant quadricuspid pulmonary valve. Interactive cardiovascular and thoracic surgery 2012. link 25 Odenwald T, Taylor AM. Pulmonary valve interventions. Expert review of cardiovascular therapy 2011. link 26 Vitanovski D, Ionasec RI, Georgescu B, Huber M, Taylor AM, Hornegger J et al.. Personalized pulmonary trunk modeling for intervention planning and valve assessment estimated from CT data. Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2009. link 27 Dod H, Bhardwaj R, Singh P, Massinople D, Sajja V, Williams HJ et al.. Two-dimensional echocardiographic findings of pulmonary valve cyst secondary to pulmonary valvuloplasty. Echocardiography (Mount Kisco, N.Y.) 2009. link 28 Godart F, Bouzguenda I, Juthier F, Wautot F, Prat A, Rey C et al.. Experimental off-pump transventricular pulmonary valve replacement using a self-expandable valved stent: A new approach for pulmonary incompetence after repaired tetralogy of Fallot?. The Journal of thoracic and cardiovascular surgery 2009. link 29 Silva AM, Dallan LA, Campagnucci VP, Caruso J, Gandra SM, Rivetti LA. Approach of the pulmonary valve using right heart bypass and bicaval cannula: experimental study. Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular 2007. link 30 Ansari A. Isolated pulmonary valvular regurgitation: current perspectives. Progress in cardiovascular diseases 1991. link90024-g)

Pulmonary valve disorder